Federal Contractor Profile
Janssen Pharmaceuticals, INC.
$944M obligated·2 awards·1 agencies·1 NAICS
Federal Contracts
Showing contracts 1–13 of 13 total. Sorted by action date, most recent first. Excludes $0 modifications.
| Date | Agency | PIID | NAICS | Description | Amount |
|---|---|---|---|---|---|
| Mar 15, 2021 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $32M |
| Nov 13, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $454M |
| Aug 20, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $85M |
| May 12, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500014C | 541711 | IGF::OT::IGF | $35M |
| Mar 27, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $456M |
| Mar 20, 2020 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $148M |
| Dec 27, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $41M |
| Jan 13, 2018 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500014C | 541711 | IGF::OT::IGF | $24M |
| Sep 5, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500014C | 541711 | IGF::OT::IGF | $9.9M |
| Aug 15, 2017 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201700018C | 541711 | ASPR-17-03390 -- JANSSEN INFLUENZA PORTFOLIO -- ADVANCED DEVELOPMENT CANDIDATES (OTHER TRANSACTIONAL AUTHORITY) | $44M |
| May 13, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500014C | 541711 | IGF::OT::IGF | $1.9M |
| Apr 4, 2016 | Department of Health and Human ServicesBARDA - ASPR / DAAPPO / BARDA DCMA | HHSO100201500014C | 541711 | IGF::OT::IGF | $2.1M |
| Dec 8, 2015 | Department of Health and Human ServicesOFF ASST SEC ADM AND MGMT | HHSO100201500014C | 541711 | IGF::OT::IGF | $2.8M |
Get Alerted Before Janssen Pharmaceuticals, INC.'s Next Recompete
Mindy monitors active contracts and flags recompetes 12 months out so you can position to compete.
Start Free